STAGE III LARYNGEAL CANCER AJCC V8
Clinical trials for STAGE III LARYNGEAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE III LARYNGEAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE III LARYNGEAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients who Can't take standard chemo
Disease control OngoingThis early-stage trial is testing a new drug called peposertib combined with radiation therapy for patients with advanced head and neck cancer who cannot take the standard chemotherapy drug cisplatin. The main goals are to find the safest and most effective dose of peposertib and…
Matched conditions: STAGE III LARYNGEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo therapy shows promise in fighting throat cancer, sparing Patients' voices
Disease control OngoingThis study tested a combination of three drugs—two chemotherapy drugs and an immunotherapy drug—as the main treatment for stage II-III larynx (voice box) cancer. The goal was to see if this approach could effectively control the cancer while allowing patients to keep their larynx…
Matched conditions: STAGE III LARYNGEAL CANCER AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC